Thursday, November 09, 2023 5:59:54 PM
Even if we release our Q2 and Q3 10-Q's next week, I will look at Q3's 'management discussion' and 'subsequent events' portions of the filing. I still think a business arrangement of some sort with Novavax will yield the best revenue-related news we could hope for. And I don't think management is as concerned as they previously were about funds.
So maybe we will hear about a Priority Review Voucher associated with approval of lenz to treat CMML. I just saw a PRV sold for $105M.
Keep in mind that the first recall of our loaned shares caused a massive increase in share price without any other news, except for announcing an accumulation of a 50% ownership stake by Shkreli, which increased to 70%. I think we could announce a 92% ownership stake, if management has 110M of the 119M shares they have issued.
I just hope that we don't file another NT10-Q for the 3rd quarter. But I agree with you that we need to see "visible action occurring." So if another NT10-Q is necessary until we get regulatory approval, or whatever is necessary, we'll just have to deal with it, which I don't want to think about anymore than management does.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM